ORELOX

This brand name is authorized in Germany, France, Italy, Malta, Mexico, Nigeria, Tunisia, South Africa

Active ingredients

The drug ORELOX contains one active pharmaceutical ingredient (API):

1 Cefpodoxime UNII 2TB00A1Z7N - CEFPODOXIME PROXETIL

Like other beta-lactam drugs, cefpodoxime exerts antibacterial activity by binding to and inhibiting the action of certain bacterial cell wall synthetic enzymes, namely the penicillin binding proteins. Read about Cefpodoxime

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ORELOX Film-coated tablet / Granules	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DD13	Cefpodoxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 03978781, 04644622, 04765550, 07239253, 07239276
Country: FR	Base de données publique des médicaments	Identifier(s): 61923059, 65528337
Country: IT	Agenzia del Farmaco	Identifier(s): 027970019, 027970033, 027970045
Country: MT	Medicines Authority	Identifier(s): MA1359/02401, MA1359/02402
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 172M93, 181M92
Country: NG	Registered Drug Product Database	Identifier(s): A4-2723, A4-2816
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5363021, 5363022, 5363023, 9263221, 9263222, 9263223, 9263224
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/20.1.1/0564, A38/20.1.1/0406, Z/20.1.1/7